Not Medicare Enrolled

Dr. Jennifer Deaver, MD

Dermatology · Houston, TX
Speaking/Promotional
550 POST OAK BLVD STE 550, Houston, TX 77027
7134971417
In practice since 2007 (18 years)
NPI: 1164614913 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deaver from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deaver? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deaver

Dr. Jennifer Deaver is a dermatology in Houston, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Deaver received a total of $107,875 from 37 pharmaceutical and/or device companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deaver is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $107,875 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$107,875
Total received (2018-2024)
Avg $15,411/year across 7 years
Top 6% in TX for dermatology
37
Companies
383
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$84,483 (78.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,470 (15.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,922 (6.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,276
2023
$32,708
2022
$3,141
2021
$6,919
2020
$10,106
2019
$9,884
2018
$43,842

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Galderma Laboratories, L.P.
$63,610
Lumenis, Inc
$20,921
Merz North America, Inc.
$11,793
MERZ NORTH AMERICA, INC.
$6,977
ABBVIE INC.
$710
Almirall LLC
$288
Arcutis Biotherapeutics, Inc.
$273
Janssen Biotech, Inc.
$261
Incyte Corporation
$260
PFIZER INC.
$241
Mayne Pharma Inc.
$229
Allergan Inc.
$228
Amgen Inc.
$216
Allergan, Inc.
$214
Encore Dermatology Inc.
$179
LEO Pharma Inc.
$170
Novartis Pharmaceuticals Corporation
$163
AbbVie Inc.
$152
Regeneron Healthcare Solutions, Inc.
$146
AbbVie, Inc.
$120
Solta Medical, a division of Bausch Health US, LLC
$87
E.R. Squibb & Sons, L.L.C.
$83
UCB, Inc.
$74
Verrica Pharmaceuticals Inc.
$66
Ortho Dermatologics, a division of Bausch Health US, LLC
$59
Lilly USA, LLC
$59
DERMIRA, INC.
$45
Celgene Corporation
$45
VYNE Pharmaceuticals Inc.
$39
Mylan Pharmaceuticals Inc.
$37
GENZYME CORPORATION
$25
EPI Health, LLC
$22
MAYNE PHARMA COMMERCIAL LLC
$18
Sun Pharmaceutical Industries Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Vifor Pharma, Inc.
$17
Journey Medical Corporation
$13
Top 3 companies account for 89.3% of total payments
Associated products mentioned in payments ›
ABSORICA · ADBRY · AKLIEF · ALTRENO · AMZEEQ · Amnesteem · BOTOX · BOTOX COSMETIC · Bimzelx · COSENTYX · Cabtreo · Cimzia · DORYX · DUPIXENT · DYSPORT · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · FINACEA · Finacea · HUMIRA · Humira · Impoyz · Klisyri · OPZELURA · ORACEA · Olux · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · TRILUMA · TWYNEO · Veltassa · XEOMIN · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for dermatology in TX.

Looking for a dermatology in Houston?
Compare dermatologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
254
Per 100K population
5.3
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
2.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Deaver is a dermatology, and high industry engagement (speaking/promotional, top 6%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Deaver receive payments from pharmaceutical companies?
Yes. Dr. Deaver received a total of $107,875 from 37 companies across 383 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Deaver) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →